47
Views
1
CrossRef citations to date
0
Altmetric
Original Articles

Identifying experiences of individuals with Type 2 diabetes during acceptance and adaptation of insulin therapy

&
 

Abstract

This study was carried out in a qualitative manner in order to identify the emotions and life experience of the patients with Type 2 diabetes with regard to their acceptance of insulin therapy and their experience during adaptation process disease in the Endocrinology Clinic of Ondokuz Mayıs University between December 2014 through April 2015. The data was collected by employing interview form and in-depth interview. A voice recording was made in the interviews which lasted at least 5 minutes and written minutes of the data were issued within 24 hours following the interview. The content analysis was utilized in analyzing the qualitative and statistical data in connection with the demographic characteristics. In accordance with the results of the analysis, four groups and totally 14 themes are identified in which the obtained results are classified. For the purpose of ensuring the acceptance by the patients of the therapy and their adaptation to the process, it is suggested to mention about insulin therapy at the initial phase of the diabetes training, and provide assistance for the adaptation of insulin therapy through a sympathetic approach by making a planing based upon the individual needs.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.